Bellevue Life Sciences Acquisition Corp. Uncategorized Contracts & Agreements
17 Contracts & Agreements
- First Amendment to Amended and Restated Business Combination Agreement, dated as of December 20, 2024 between Bellevue Life Sciences Acquisition Corp. and OSR Holdings Co., Ltd (Filed With SEC on December 23, 2024)
- Amended and Restated Business Combination Agreement, dated as of May 23, 2024, between Bellevue Life Sciences Acquisition Corp. and OSR Holdings Co., Ltd (Filed With SEC on May 30, 2024)
- Business Combination Agreement, dated as of November 16, 2023, between Bellevue Life Sciences Acquisition Corp. and OSR Holdings Co., Ltd (Filed With SEC on November 16, 2023)
- Description of Securities (Filed With SEC on March 31, 2023)
- Amended and Restated Administrative Support Agreement, dated February 9, 2023, by and between the Company and the Sponsor (Filed With SEC on February 15, 2023)
- Form of Amended and Restated Administrative Support Agreement by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on January 20, 2023)
- Amended and Restated Administrative Support Agreement, dated November 4, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on November 4, 2022)
- Amended and Restated Administrative Support Agreement, dated , 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on October 7, 2022)
- Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC (Filed With SEC on October 7, 2022)
- Specimen Rights Certificate (Filed With SEC on October 7, 2022)
- Specimen Unit Certificate (Filed With SEC on October 7, 2022)
- Administrative Support Agreement, dated April 20, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 10, 2022)
- Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 10, 2022)
- Administrative Support Agreement, dated April 20, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 29, 2022)
- Form of Indemnity Agreement (Filed With SEC on April 29, 2022)
- Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 29, 2022)
- Specimen Unit Certificate (Filed With SEC on April 29, 2022)
